Delivery Order SPE2DR25D3301-SPE2DR26F22EC

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, with a ceiling value of $16,368.44 for CABENUVA ER 600 MG-900 MG suspension 6 mL pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 2, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL units, with a contract ceiling value of $4,022.43 and an ultimate completion date of November 13, 2025. This firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,184.22 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on January 15, 2026, with an ultimate completion date of February 6, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...

The Defense Logistics Agency awarded a delivery order valued at $8,044.86 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on December 22, 2025, with completion scheduled for January 14, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...

The Defense Logistics Agency awarded a $4,022.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) with an ultimate completion date of November 13, 2025. This competitively awarded, non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. This delivery order is...

The Defense Logistics Agency awarded a delivery order valued at $18,617.58 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation, performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the Defense...

The Defense Logistics Agency awarded a delivery order valued at $3,816.90 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...

The Defense Logistics Agency awarded a delivery order valued at $7,633.82 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 ml units. This firm fixed price delivery order, with an ultimate completion date of November 18, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. Cabenuva is a long-acting injectable antiretroviral combination therapy...

The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,562.45 on December 11, 2025, for CABENUVA ER 600 MG-900 MG suspension (6 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled to conclude by January 5, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical...